论文部分内容阅读
目的探讨2型糖尿病患者微量白蛋白尿(MAU)与冠心病(CHD)的关系。方法98例2型糖尿病患者,依有无并发CHD分为糖尿病并CHD组(28例)和糖尿病不并CHD组(70例),分析比较两组心血管疾病危险因素。再依微量白蛋白尿含量分为微量白蛋白尿组(43例)和非白蛋白尿组(55例),比较两组CHD的发生率。结果糖尿病并CHD组微量白蛋白尿含量明显高于不并CHD组[(56±32)mg/L和(22±15)mg/L,P<0.01];微量白蛋白尿组并发CHD的发生率显著高于非白蛋白尿组(41.86%和18.18%,P=0.01)。结论检测微量白蛋白尿是预测2型糖尿病患者CHD发病率的有意义的指标。
Objective To investigate the relationship between microalbuminuria (MAU) and coronary heart disease (CHD) in type 2 diabetic patients. Methods A total of 98 patients with type 2 diabetes mellitus (T2D) were divided into two groups according to the presence of CHD: diabetic CHD group (n = 28) and diabetes without CHD group (n = 70). The risk factors for cardiovascular disease were analyzed. According to the microalbuminuria, the patients were divided into microalbuminuria group (43 cases) and non-albuminuria group (55 cases). The incidence of CHD was compared between the two groups. Results The levels of microalbuminuria in diabetic CHD group were significantly higher than those in CHD group (56 ± 32 mg / L and (22 ± 15) mg / L, P <0.01] The rates were significantly higher in the non-albuminuria group (41.86% and 18.18%, P = 0.01). Conclusion The detection of microalbuminuria is a significant indicator of the incidence of CHD in type 2 diabetic patients.